Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Innovation1 Biotech Inc. IVBT

Innovation1 Biotech Inc is a pharmaceutical, small molecule, research and development company focused on the discovery and clinical development of novel therapeutics for major unmet medical needs. The company's portfolio includes five proprietary, fully synthetic preclinical prodrugs addressing independent clinical indications: a mushroom-derived psychedelic molecule for treatment of post-traumatic stress disorder and depression, a novel cannabinoid for treatment of addiction and three additional cannabinoid prodrugs addressing clinical indications of refractory epilepsy, burn wounds and uveitis.


Company Profile & Information (OTCQB:IVBT)

Showcase News Releases

Showcase news

Mandalay Resources Corp
Mandalay Resources Corporation Announces Financial Results for the Second Quarter 2022
Vertex Resource Group Ltd.
VERTEX RESOURCE GROUP LTD. REPORTS RECORD SECOND QUARTER 2022 RESULTS
Orvana Minerals Corp
ORVANA REPORTS CONSOLIDATED FINANCIAL RESULTS FOR THE THIRD QUARTER OF FISCAL 2022

More Showcase News Releases »